Morphological analysis of the skeletal development in lateral cephalometric radiographs of HIV infected children ongoing Highly Active Antiretroviral Therapy by Possagno, Letícia-Pereira et al.
Med Oral Patol Oral Cir Bucal. 2018 Nov 1;23 (6):e691-7.                                                                                                                                                        Vertebral development in HIV children
e691
Journal section: Medically compromised patients in Dentistry
Publication Types: Research
Morphological analysis of the skeletal development in lateral 
cephalometric radiographs of HIV infected children ongoing 
Highly Active Antiretroviral Therapy
Letícia-Pereira Possagno 1, Ademir Franco 2, Luiz-Renato Paranhos 3, Liliane-Janete Grando 4, Antonio-Adil-
son-Soares de Lima 1, Ilana-Sanamaika-Queiroga Bezerra 5, Ângela Fernandes 1
1 Department of Stomatology, Federal University of Paraná, Brazil
2 Department of Therapeutic Stomatology, Institute of Dentistry, Sechenov University, Russia
3 Department of Preventive and Community Dentistry, School of Dentistry, Federal University of Uberlândia, Brazil
4 Department of Pathology, Center of Health Sciences, Federal University of Santa Catarina, Brazil
5 Department of Radiology and Imaging, Technical School of Oral Health, Federal University of Campina Grande, Brazil
Correspondence:
Department of Stomatology
Federal University of Paraná 
Av. Prefeito Lothário Meissner 632





Background: To investigate the skeletal development of HIV infected children through a morphological analysis 
of the cervical vertebrae (CV) in lateral cephalometric radiographs. 
Material and Methods: The sample consisted of 86 lateral cephalometric radiographs of male and female children 
aged between 6 and 14 years old. The radiographs were equally distributed in groups 1 (HIV infected children) 
and 2 (non-infected children, paired by sex and age). Two examiners analyzed the CV according to the method of 
Hassel and Farman (1995). Spearman correlation coefficient was used to associate age and skeletal development 
within groups, while Mann-Whitney test compared the skeletal development between groups. 
Results: The correlation of age and skeletal development in group 1 reached 0.17, 0.27 and 0.27 (p>0.05) for C2, 
C3 and C4, respectively, while in group 2 it reached 0.65, 0.54 and 0.60, respectively (p<0.001). Differences were 
not significant between groups (p>0.05). 
Conclusions: HIV infected and non-infected children showed a similar development of the CV. However, the weak 
correlation between age and CV development in HIV infected children highlights the need for careful decisions 
prior to therapeutic approaches – especially those founded on the prediction of skeletal development, such as max-
illofacial surgeries, and orthopedic and orthodontic procedures.
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Introduction
Since the peak of the Human Immunodeficiency Vi-
rus (HIV) in 1997 (1) different strategies strived to 
promote health in face of this global threat. However, 
recent surveillance reports on the transmission of the 
HIV presented controversial rates worldwide (1). While 
in industrialized countries the number of HIV infected 
persons decreased, it remained stable or even increased 
among developing countries (2). In the last, pediatric 
HIV through vertical transmission (mother-to-child) 
figures as a social problem and an eminent cause of 
mortality (3). Over the last years, the Highly Active An-
tiretroviral Therapy (HAART) enabled longer life ex-
pectancy to children (4). On the other hand, the biologi-
cal side effects of both HIV and HAART became daily 
challenges to be considered in order to provide better 
quality of life to children.
HIV infected children may manifest systemic altera-
tions that impact on growth and development (3). In 
specific, the scientific literature has shown evidences 
that point towards a delayed growth (3-5). When associ-
ated with HIV, the delayed growth may manifest from 
endocrine and gastrointestinal disorders and recurrent 
infections (3). Differently, other authors (4) show that 
growth alterations may be related to aspects other than 
viral, such as poverty, tuberculosis and malnutrition (4). 
When associated with HAART, the eventual delayed 
growth may be an expression of the combination of 
toxic drugs (5). Protease inhibitors emerge in this con-
text as substances known for their impact in osteoclast 
differentiation and bone metabolism (5). In this context, 
both the HIV itself and the HAART could play a role 
in the alleged delayed growth in HIV infected children. 
In Dentistry, maxillofacial surgery, orthodontics and 
skeletal orthopedics figure as important fields in the 
treatment of functional and aesthetic growth disorders. 
The therapeutic approaches in these fields often require 
radiographic analysis is to screen skeletal morphology 
and to intercept skeletal disorders with optimal timing 
(6). The analysis of skeletal development through carpal 
radiographs was a common practice along the last de-
cades (7). However, the additional exposure to radiation 
for the assessment of the hand and wrist consisted of an 
important limitation of the technique (8). Triggered by 
the increasing concern with radiation protection, the as-
sessment of the cervical vertebrae (CV) through lateral 
cephalometric radiographs emerged as an alternative in 
the clinical practice (9,10). 
Despite the advances in radiology for the assessment of 
skeletal development to therapeutic purposes, no study 
was carried to this moment investigate the radiographic 
development of the CV in HIV infected children. In or-
der to support evidence-based practices and decisions 
in Dentistry, this study aimed to assess the development 
of the CV of HIV infected children ongoing HAART.
Material and Methods
-Ethical criteria and protocol
The present study was conducted after the approval of 
the local Committee of Ethics in Research (protocol 
#1.479.700). All the ethical criteria for human research 
were followed, including the application of informed 
consent forms to the individuals sampled or their rela-
tives.
-Study design and sampling
The sample consisted of 86 children divided in two 
study groups (Table 1). Group 1 (n=43) was formed by 
male (n=18) and female (n=25) children aged between 
6 and 14 years old (mean age: 10.26 ± 1.71 years). The 
children in this group were sampled by convenience af-
ter diagnosed with HIV by a Pediatrician via serologi-
cal tests at the Department of Infectology at a pediatric 
hospital. All the children were vertically infected and 
received HAART since birth. According to medical re-
cords, their average TCD4+ lymphocyte count reached 
35% and VL log10 of 3.25%, which represent controlled 
and ideal clinical conditions for asymptomatic children 
with HIV. Additionally to the diagnosis of HIV, the 
vertical infection and the use of HAART, the inclusion 
criteria for sampling group 1 also considered children 
that necessarily underwent treatment in both the De-
partment of Infectology and the Dental Service at the 
University Hospital. The exclusion criteria consisted of 
children with clinical body malformations and previous 
medical history of fractures or surgeries in the neck. 
Group 2 (n=43) consisted of male (n=18) and female 
(n=25) children aged between 6 and 14 years old (mean 
age: 10.17 ± 1.68 years) not infected by the virus. This 
group was sample arbitrarily from the Department of 
Dentistry at the pediatric hospital to match group 1 by 
Group n M F Age range Mean SD TCD4+ VL log10 p
1 43 18 25 6-14 10.26 1.71 35% 3.25%
0.795
2 43 18 25 6-14 10.17 1.68 - -
Table 1. Demographic and clinical data of the children sampled in groups 1 and 2.
Group 1: children infected with HIV; Group 2: children not infected with HIV; n: number of children sampled in each group; M: males; 
F: females; Age range, mean age and standard deviation (SD) of children expressed in years; TCD4+: lymphocyte count; VL log10: 
viral load count; p: lack of statistically significant differences between the mean ages of both groups considering a significance level 
of 5%. 
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sex and age (e.g. for each HIV infected female aged 10 
years old there was a non-infected female with the same 
age). Thus, the inclusion criteria consisted of sex and 
age matching group 1. The age matching process was 
performed allowing a maximum tolerance of 90 days 
between the children in both groups. The exclusion cri-
teria in this group consisted of systemic diseases, body 
malformation and previous medical history of fractures 
and surgeries in the neck. In both groups the informa-
tion on the exclusion criteria was extracted from the an-
amnesis, and from the medical and dental records.
The children in both groups underwent treatment at the 
Dental Service at the University Hospital. Out of their 
dental records lateral cephalometric radiographs were 
retrospectively retrieved and used in the present study. 
All the radiographs were taken exclusively for therapeu-
tic purposes. The radiographs were taken with an ana-
log Veraview® (J. Morita®, Kyoto, Japan) panoramic 
device set at 62-66kV, 8-10mA and exposure time of 
8-10 seconds. During 2.5 minutes, each radiograph un-
derwent automatic processing (Revell®, São Paulo, SP, 
Brazil). Next, the radiographs were scanned in 300ppi 
using a HP Scanjet G4050® (Hewlett-Packard Co.®, 
Palo Alto, CA, USA) device and stored as .TIFF files. 
-Data extraction
The digital radiographic files were provided to a trained 
examiner that proceeded with the analyses of the CV ac-
Fig. 1. Radiographs of the six skeletal stages proposed by Hassel and Farman (9) for the development of the cervical vertebrae C2, 
C3 and C4.
The images presented from A to F represent an approximation of the six developmental stages of the cervical vertebrae, namely the 
initiation (I), acceleration (II), transition (III), deceleration (IV), maturation (V) and completion (VI). According to the Hassel and 
Farman (9) in the initiation flat borders are observed in the inferior surface of all the vertebrae while the upper surface is tapered in 
the posteroanterior direction. In the acceleration the lower surface of C4 remains flat while in C2 and C3 it start becoming concave. 
The concavities in C2 and C3 become more distinct in the transition stage while in C4 it starts developing. Moreover, C3 and C4 
present a rectangular shape. In deceleration all the vertebrae have a distinct concavity in the lower surface and the shape of C3 and 
C4 is closer to a square. In the maturation stage the concavities in all the vertebrae become more evident and C3 and C4 assume 
a squared shape. Finally, in completion, the concavities are evidently deep in the three vertebrae and C3 and C4 present vertical 
dimensions larger than horizontal dimensions. For orthodontic purposes, the authors (9) indicate that in stages I, II, III, IV, and V 
very significant, significant, moderate, small and insignificant growth may be expected, while in stage VI growth is completed (9). 
Images A-E were retrieved from the main sample, while image F was retrieved from the examiner agreement sample.      
cording to the method proposed by Hassel and Farman 
(1995) (9). The method is founded on a staging technique 
in which three CV, namely C2, C3 and C4, are classi-
fied into six developmental stages, namely I) initiation; 
II) acceleration; III) transition; IV) deceleration; V) 
maturation and VI) completion (Fig. 1) (9). The images 
were analyzed in a personal computer using software 
packages for image viewing and contrast manipulation 
(Adobe Photoshop CS5®, Adobe Systems®, San Jose, 
CA, USA). The examiner was blind for the sex, age and 
health condition of the patient in each radiograph. In 
order to assess the examiner reproducibility, intra- and 
inter-examiner agreement tests were performed. In the 
first, the main examiner analyzed 25 lateral cephalo-
metric radiographs following the method previously 
described and performed a second and a third analysis 
7 (n=25) and 14 (n=25) days later, respectively. In the 
second, an additional examiner was included to analyze 
the same 25 radiographs. All the radiographs used in 
the examiner agreement tests were did not belong to the 
main sample. They were collected retrospectively from 
the university database.
-Data analysis
T-test for independent samples was used to compare the 
patients’ age in groups 1 and 2. This procedure was nec-
essary to validate the sample pairing process on match-
ing the patients by their age. Spearman correlation coef-
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ficient was used to associate the age of patients within 
each group with the respective developmental stage of 
their CV. Mann-Whitney test was applied to compare 
the developmental stages of the CV between groups 
with and without sex stratification. Intra- and inter-ex-
aminer agreement tests were quantified with Weighted 
Kappa test. Statistical tests were performed with Statis-
tica 13.0 (StatSoft Inc., Tulsa, OK, USA) software pack-
age and their statistical significance was set in 5%. 
Results 
The t-test for independent samples pointed no differ-
ences statistically significant between the age of the 
patients sampled in group 1 and 2 (p=0.795). More spe-
cifically, the mean age among HIV infected children 
was 10.26 years (±1.71) while in non-infected children 
the mean age was 10.17 years (±1.68). When the assess-
ment of sample matching was performed comparing 
the age of males and females in each group the lack of 
differences statistically significant remained (group 1: 
p=0.192; group 2: p=197).
Spearman correlation coefficient showed a positive cor-
relation (r>0) between the age and the developmental 
stage of the CV within groups 1 and 2. The coefficient 
of determination in children infected with HIV ranged 
from 0.17 to 0.29, while in children not infected with the 
virus it ranged between 0.54 and 0.65. The correlation 
was statistically significant for all the CV in the age of 
group 2 (p<0.001), while in group 1 it was not (p>0.05) 
(Table 2).
Mann-Whitney test showed no difference statistically 
significant between children infected and not infected 
with HIV for all the CV (Table 3) (p>0.05). The most 
similar distribution of the developmental stages be-
tween groups was observed for C2 (p=0.810), followed 
by C4 (p=0.530) and C3 (p=0.513). 
Comparisons on the distribution of developmental stag-
es between males and females did not reach statistically 
significant differences (p>0.05). In children infected 
with HIV the most similar distribution of the develop-
mental stages was observed in C4 (p=0.913), followed 
by C2 (p=0.798) and C3 (p=0.335). In children not in-
fected with the virus the similarity of distribution fol-
lowed the same pattern (C4: p=0.990; C2: p=0.652; C3: 
p=0.400) (Table 4).   
Intra- (0.79) and inter-examiner (0.85) agreement tests 
reached great and excellent outcomes, respectively.
Discussion
Equity for accessing proper health treatment is a global 
concern, especially regarding maxillofacial orthopedics 
and orthodontics (11-16). In this context, HIV infected 
children figure as a population under the need of major 
attention on health care. Screening the skeletal develop-
ment in this population is an important step to guide 
surgical and orthopedic procedures. Based on it, the 
present study was designed to investigate the CV de-
velopment in lateral cephalometric radiographs of HIV 
infected children.
In order to design a systematic and standardized ra-
diographic assessment of the development of the CV, 
sample matching was performed. Similar strategy was 
previously performed in studies on craniofacial (17) and 
dental (18) development of HIV infected children. To 
accomplish this task a reference sample (group 2: non-
infected children, mean age: 10.17 years ±1.68) with age 
and sex compatible with the study group (group 1: HIV 
infected children, 10.26 years ±1.71) was selected. Suc-
cess in sample matching was confirmed with the lack 
of statistically significant differences between the mean 
ages of both groups. This procedure contributed to avoid 
age-related bias in the comparison between groups.
The patients’ age (independent variable) was tested 
based on their correlation with the developmental 
stages of the CV (dependent variable) in both groups. 
Positive correlations were observed (Table 2), but they 
were statistically significant (p=0.001) only in group 2. 
The coefficient of determination (r) expressed in group 
2 ranged between moderate and strong (from 0.54 to 
0.65), which indicates that in group 2 a high propor-
tion of variance in the developmental stages is detect-
able from the chronological age. Similar outcomes were 
observed in previous studies correlating the method of 
Hassel and Farman (9) (1995) with the chronological age 
in populations with no systemic diseases (18,19). In HIV 
infected children, growth may be affected (20) leading 
to a delayed skeletal development (21). Consequently, 
Vertebrae Group r p
C2 1 0.17 0.288 
2 0.65 <0.001
C3 1 0.27 0.077
2 0.54 <0.001
C4 1 0.29 0.056 
2 0.60 <0.001
Table 2. Correlation between the developmental stages of the cervi-
cal vertebrae and the age of patients sampled within group 1 and 2.
Group 1: children infected with HIV; Group 2: children not infected 
with HIV; r: coefficient of determination; p: statistical difference 
considering a significance of 5%.
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Vertebrae      Group Stages Total p
1 2 3 4
C2
1 1 (2.3%) 17 (39.5%) 22 (51.2%) 3 (7%) 43 (100%) 
0.8102 0 (0%) 17 (39.5%) 23 (53.5%) 3 (7%) 43 (100%)
Total 1 (1.2%) 34 (39.5%) 45 (52.3%) 6 (7%) 86 (100%)
C3
1 1 (2.3%) 25 (58.1%) 14 (32.6%) 3 (7%) 43 (100%)
0.5302 0 (0%) 30 (69.8%) 11 (25.6%) 2 (4.7%) 43 (100%)
Total 1 (1.2%) 55 (64%) 25 (29.1%) 5 (5.8%) 86 (100%)
C4
1 2 (4.7%) 34 (79.1%) 5 (11.6%) 2 (4.7%) 43 (100%)
0.5132 1 (2.3%) 32 (74.4%) 8 (18.6%) 2 (4.7%) 43 (100%)
Total 3 (3.5%) 66 (76.7%) 13 (15.1%) 4 (4.7%) 86 (100%)
Table 3. Distribution of the developmental stages of the cervical vertebrae C2, C3 and C4 in children infected and not infected with HIV and 
the respective comparison between groups.
Group 1: children infected with HIV; Group 2: children not infected with HIV; Stages 1-4: initiation, acceleration, transition and deceleration, 
respectively; p: statistical difference considering a significance of 5%. 
Group Vertebrae Sex 1 2 3 4 Total (100%) p
1
C2
M 1 (5.6%) 6 (33.3%) 11 (61.1%) 0 18
0.798F 0 11 (44%) 11 (44%) 3 (12%) 25
Total 1 (2.3%) 17 (39.5%) 22 (51.2%) 3 (7%) 43
C3
M 1 (5.6%) 11 (61.1%) 6 (33.3%) 0 18
0.335F 0 14 (56%) 8 (32%) 3 (12%) 25
Total 1 (2.3%) 25 (58.1%) 14 (32.6%) 3 (7%) 43
C4
M 1 (5.6%) 14 (77.8%) 3 (16.7%) 0 18
0.913F 1 (4%) 20 (80%) 2 (8%) 2 (8%) 25
Total 2 (4.7%) 34 (79.1%) 5 (11.6%) 2 (4.7%) 43
2
C2
M 0 11 (44%) 12 (48%) 2 (8%) 25
0.652F 0 6 (33.3%) 11 (61.1%) 1 (5.6%) 18
Total 0 17 (39.5%) 23 (53.5%) 3 (7%) 43
C3
M 0 16 (64%) 7 (28%) 2 (8%) 25
0.400F 0 14 (77.8%) 4 (22.2%) 0 18
Total 0 30 (69.8%) 11 (25.6%) 2 (4.7%) 43
C4
M 1 (4%) 18 (72%) 4 (16%) 2 (8%) 25
0.990F 0 14 (77.8%) 4 (22.2%) 0 18
Total 1 (2.3%) 32 (74.4%) 8 (18.6%) 2 (4.7%) 43
Table 4. Distribution of the developmental stages of the cervical vertebrae C2, C3 and C4 in male and female children infected and not 
infected with HIV and the respective comparison.
Group 1: children infected with HIV; Group 2: children not infected with HIV; M: males; F: females; Stages 1-4: initiation, acceleration, 
transition and deceleration, respectively; p: statistical difference considering a significance of 5%.
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the correlation between the developmental stages of the 
CV and age may be altered. Very weak and weak coef-
ficients of determination in group 1 (from 0.17 to 0.29, 
p>0.05) confirm this statement. Considering the aim of 
this study, these outcomes point towards the need for 
careful steps into procedures that involve the prediction 
of growth from CV in HIV infected children. The weak 
correlation between age and the stages of skeletal devel-
opment in group 1 indicates that in the clinical practice 
the radiographic assessment of the cervical vertebrae 
may be unreliable to predict maxillofacial growth and 
consequently planning therapeutic approaches.
Despite the lack of statistically significant correlation 
between the stages of CV development and the age of 
children infected with HIV (group 1), the skeletal de-
velopment between groups did not differ significantly 
(p>0.05) (Table 3). Additionally, comparisons based on 
sex also did not reach statistically significant differenc-
es (p>0.05) (Table 4). To our knowledge, no study was 
previously designed to assess the development of the 
CV in HIV patients. The available scientific literature 
is scarce and focuses on the radiographic assessment 
of the hand and wrist (21,22), the teeth (19,22,23) and 
the craniofacial bones (18). In the clinical practice, in-
formation on the skeletal development of HIV infected 
children through the CV is relevant for any therapeutic 
approach that requires that analysis and the prediction 
of growth. More solid and palpable application is found 
in dentomaxillofacial orthodontics and orthopedics, in 
which lateral cephalometric radiographs became part of 
the treatment planning.
The exact reason why the skeletal development is af-
fected in children with HIV is complex and uncertain 
among authors in the scientific literature. In one hand, 
studies show that HIV may cause hypovitaminosis 
D (24). Vitamin D has a role in maintaining Calcium 
available in serum levels (25) and a consequent part in 
avoiding risk of bone alterations. Long-term lack of bal-
ance of vitamin D and Calcium could trigger alterations 
in the development of the CV in HIV patients. How-
ever, in the present study, all the patients sampled were 
children controlled with HAART. Their clinical condi-
tion with drug control was adequate based on TCD4+ 
and VL log10 count and for this reason evident bone 
alterations in lateral cephalometric radiographs was not 
expected (based on solely on HIV itself). In the other 
hand, the HAART combines several drugs that are toxic 
and may have association with disorders in bone me-
tabolism (26). These drugs are known for their impact 
in osteoclastic activity and potential association with 
osteoporosis and osteopenia. Among these drugs, pro-
tease inhibitors figure as potentially influent in decreas-
ing bone mineral density (26). Additionally, these drugs 
also may have a potential impact over the availability 
of vitamin D and Calcium. Specifically, in vitro stud-
ies show a suppression of 25- and 1-alpha-hydroxilase 
– important components on the synthesis of vitamin D 
(27,28). Again, the lack of vitamin D in optimal levels 
has a negative impact in Calcium homeostasis. Radio-
graphic bone alterations could be expected in the patient 
sampled is this study because all of them were infected 
by HIV and were controlled with HAART since birth. 
However, tracking the potential influence of HAART in 
HIV infected children and adolescents or even screen-
ing their laboratory blood tests for vitamin D count is a 
task for further investigations. 
Other investigations are also encouraged to overcome 
the limitations found in the present study, especially the 
small sample in the control group. Control groups have 
an important part in providing more reliability to the re-
search methods (29). Matching case and control groups 
in a ratio above 1:2 (preferably near to 1:4) would bene-
fit future studies with a major statistical power (30). Fol-
lowing the sampling approach of the present study, case 
and control matching by sex and age should be main-
tained to avoid eventual and inherent bias. Additional 
alternatives for scientific investigations may include 
homogeneous sampling in different age limits and the 
use of other radiographic methods for the assessment of 
skeletal development. These methodological improve-
ments would enable not only the assessment of skeletal 
development but also age estimation between HIV in-
fected and not infected children. 
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